Step-by-step explanation:
When caring for a client with cystic fibrosis who is taking Pancrelipase and experiencing a new onset of steatorrhea (fatty stools), the nurse should make the following statement:
b. "You should take this medication with food."
Pancrelipase is a pancreatic enzyme replacement medication used in cystic fibrosis to aid in digestion and absorption of fats, proteins, and carbohydrates. It helps compensate for the deficient pancreatic enzyme production in individuals with cystic fibrosis. Taking Pancrelipase with food is important because it allows the medication to mix with the food in the stomach, facilitating the breakdown and absorption of nutrients.
Option a, "You should chew the medication completely," is not accurate because Pancrelipase should not be chewed. Instead, it is usually swallowed whole with a glass of water.
Option c, "You need to increase the fat intake in your diet," is not appropriate because steatorrhea indicates that the client is already experiencing poor fat absorption. Increasing fat intake would exacerbate the problem. The focus should be on improving fat digestion and absorption with the help of Pancrelipase.
Option d, "You are experiencing an adverse reaction to the medication," is not correct. Steatorrhea is a symptom indicating poor fat digestion and absorption, which is a common issue for individuals with cystic fibrosis. It does not necessarily indicate an adverse reaction to the medication.
Therefore, the most appropriate statement for the nurse to make in this scenario is option b, "You should take this medication with food." However, it is important for the client to follow the specific instructions and guidance provided by their healthcare provider regarding the timing and administration of Pancrelipase.